Literature DB >> 19480971

Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.

Anjali K Gupta1, John H Lee, Werner W Wilke, Harry Quon, Gareth Smith, Amit Maity, John M Buatti, Douglas R Spitz.   

Abstract

PURPOSE: Human papilloma virus (HPV)-associated cancers of the head and neck (H&N) are increasing in frequency and are often treated with radiation. There are conflicting data in the literature regarding the radiation response in the presence of HPV infection, with some data suggesting they may be more sensitive to radiation. There are few studies looking at in vitro effects of HPV and further sensitization by inhibitors of specific signaling pathways. We are in the process of starting a clinical trial in H&N cancer patients using nelfinavir (NFV) (which inhibits Akt) and it would be important to know the effect of HPV on radiation response +/- NFV. METHODS AND MATERIALS: Two naturally infected HPV-16 cell lines (UPCI-SCC90 and UMSCC47) and the HPV-negative SQ20B H&N squamous carcinoma cells were used. Western blots with or without 10 uM NFV were done to evaluate signaling from the PI3K-Akt pathway. Clonogenic assays were done in the three cell lines with or without NFV.
RESULTS: Both UPCI-SCC90 and UMSCC47 cells were sensitive to radiation as compared with SQ20B and the degree corresponded to Akt activation. The SQ20B cell line has an activating mutation in EGFR resulting in phosphorylation (P) of Akt; UMSCC47 has decreased P-phosphatase and TENsin (PTEN), resulting in increased P-Akt; UPCI-SCC90 had overexpression of P-PTEN and decreased P-Akt. NFV resulted in downregulation of Akt in all three cell lines, resulting in sensitization to radiation.
CONCLUSIONS: HPV-infected H&N cancers are sensitive to radiation. The degree of sensitivity correlates to Akt activation and they can be further sensitized by NFV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19480971      PMCID: PMC2766796          DOI: 10.1016/j.ijrobp.2009.03.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  38 in total

1.  The Ras radiation resistance pathway.

Authors:  A K Gupta; V J Bakanauskas; G J Cerniglia; Y Cheng; E J Bernhard; R J Muschel; W G McKenna
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 2.  The cellular response to p53: the decision between life and death.

Authors:  R V Sionov; Y Haupt
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

3.  Strength and specificity of different gene promoters in oral cancer cells.

Authors:  E J Shillitoe; S Noonan
Journal:  Oral Oncol       Date:  2000-03       Impact factor: 5.337

4.  Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells.

Authors:  Luis A Padilla; Benjamin S Leung; Linda F Carson
Journal:  Gynecol Oncol       Date:  2002-04       Impact factor: 5.482

5.  Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

Authors:  Anjali K Gupta; W Gillies McKenna; Charles N Weber; Michael D Feldman; Jeffrey D Goldsmith; Rosemarie Mick; Mitchell Machtay; David I Rosenthal; Vincent J Bakanauskas; George J Cerniglia; Eric J Bernhard; Randal S Weber; Ruth J Muschel
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

6.  Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis.

Authors:  Kristina R Dahlstrom; Karen Adler-Storthz; Carol J Etzel; Zhensheng Liu; Laura Dillon; Adel K El-Naggar; Margaret R Spitz; John T Schiller; Qingyi Wei; Erich M Sturgis
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

7.  The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil.

Authors:  Wei Li; Carol H Thompson; Yvonne E Cossart; Christopher J O'Brien; Edward B McNeil; Richard A Scolyer; Barbara R Rose
Journal:  Head Neck       Date:  2004-01       Impact factor: 3.147

Review 8.  Unravelling the activation mechanisms of protein kinase B/Akt.

Authors:  Michael P Scheid; James R Woodgett
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

9.  Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.

Authors:  Elizabeth A Sisk; Scott G Soltys; Shaobo Zhu; Susan G Fisher; Thomas E Carey; Carol R Bradford
Journal:  Head Neck       Date:  2002-09       Impact factor: 3.147

Review 10.  Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system.

Authors:  Martin Scheffner; Noel J Whitaker
Journal:  Semin Cancer Biol       Date:  2003-02       Impact factor: 15.707

View more
  45 in total

1.  Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Dirk Rades; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Steven E Schild; Christoph Thorns
Journal:  Strahlenther Onkol       Date:  2011-09-19       Impact factor: 3.621

2.  Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.

Authors:  Frank Ziemann; Andrea Arenz; Stefanie Preising; Claus Wittekindt; Jens P Klussmann; Rita Engenhart-Cabillic; Andrea Wittig
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model.

Authors:  Stephen Tuttle; Lauren Hertan; Natalie Daurio; Sarah Porter; Charanya Kaushick; Daqing Li; Shunsuke Myamoto; Alex Lin; Bert W O'Malley; Constantinos Koumenis
Journal:  Cancer Biol Ther       Date:  2012-05-01       Impact factor: 4.742

4.  Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.

Authors:  Mei Zhao; Daisuke Sano; Curtis R Pickering; Samar A Jasser; Ying C Henderson; Gary L Clayman; Erich M Sturgis; Thomas J Ow; Reuben Lotan; Thomas E Carey; Peter G Sacks; Jennifer R Grandis; David Sidransky; Nils Erik Heldin; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2011-08-25       Impact factor: 12.531

Review 5.  AKT in cancer: new molecular insights and advances in drug development.

Authors:  Prabhjot S Mundi; Jasgit Sachdev; Carolyn McCourt; Kevin Kalinsky
Journal:  Br J Clin Pharmacol       Date:  2016-06-27       Impact factor: 4.335

Review 6.  Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.

Authors:  Aarti Bhatia; Barbara Burtness
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

7.  Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus.

Authors:  Abigail I Wald; Elizabeth E Hoskins; Susanne I Wells; Robert L Ferris; Saleem A Khan
Journal:  Head Neck       Date:  2011-04       Impact factor: 3.147

8.  Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis.

Authors:  Andrea Arenz; Frank Ziemann; Christina Mayer; Andrea Wittig; Kirstin Dreffke; Stefanie Preising; Steffen Wagner; Jens-Peter Klussmann; Rita Engenhart-Cabillic; Claus Wittekindt
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

9.  Enhanced radiation sensitivity in HPV-positive head and neck cancer.

Authors:  Randall J Kimple; Molly A Smith; Grace C Blitzer; Alexandra D Torres; Joshua A Martin; Robert Z Yang; Chimera R Peet; Laurel D Lorenz; Kwangok P Nickel; Aloysius J Klingelhutz; Paul F Lambert; Paul M Harari
Journal:  Cancer Res       Date:  2013-06-07       Impact factor: 12.701

10.  Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer.

Authors:  Allen M Chen; Talia Zahra; Megan E Daly; D Gregory Farwell; Quang Luu; Regina Gandour-Edwards; Andrew T Vaughan
Journal:  Head Neck       Date:  2013-01-17       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.